ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety of and Immune Response to an HIV-1 Subtype C Vaccine (AVX101) in HIV Uninfected Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00097838
Recruitment Status : Completed
First Posted : December 1, 2004
Last Update Posted : July 2, 2012
Sponsor:
Collaborators:
HIV Vaccine Trials Network
National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by (Responsible Party):
AlphaVax, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 2009
  Actual Study Completion Date : September 2009
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):